Brief: Imunon Announces Strategic Sale Of Thermodox
21/10/2026 13:32
BRIEF-Imunon Announces Strategic Sale Of Thermodox Oct 21 (Reuters) - Imunon Inc IMNN.O:
IMUNON ANNOUNCES STRATEGIC SALE OF THERMODOX®
TO RECEIVE EQUITY STAKE, UP TO $16.50 MILLION IN MILESTONES, AND ROYALTIES
TO RECEIVE 4.76% EQUITY INTEREST IN VOXELDOX UPON FINANCING COMPLETION
DEAL CLOSING CONTINGENT ON VOXELDOX COMPLETING $2.50 MILLION FINANCING FOR PHASE 1 GLIOBLASTOMA TRIAL
ELIGIBLE FOR 3.5%-6% TIERED ROYALTIES ON NET SALES OF THERMODOX PRODUCTS
ENTERS AGREEMENT TO SELL RIGHTS TO THERMODOX TO VOXELDOX
Source text: ID:nGNX54QtrZ
Further company coverage: IMNN.O
((Reutersbriefs@thomsonreuters.com;))